- Home
- VCYT vs XENE Comparison
VCYT vs XENE Comparison
Compare VCYT & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VCYT
- XENE
- Stock Information
- Founded
- VCYT 2006
- XENE 1996
- Country
- VCYT United States
- XENE Canada
- Employees
- VCYT N/A
- XENE N/A
- Industry
- VCYT Medical Specialities
- XENE Biotechnology: Pharmaceutical Preparations
- Sector
- VCYT Health Care
- XENE Health Care
- Exchange
- VCYT Nasdaq
- XENE Nasdaq
- Market Cap
- VCYT 2.9B
- XENE 3.2B
- IPO Year
- VCYT 2013
- XENE 2014
- Fundamental
- Price
- VCYT $48.53
- XENE $44.44
- Analyst Decision
- VCYT Buy
- XENE Strong Buy
- Analyst Count
- VCYT 9
- XENE 11
- Target Price
- VCYT $43.56
- XENE $53.55
- AVG Volume (30 Days)
- VCYT 1.2M
- XENE 834.7K
- Earning Date
- VCYT 11-04-2025
- XENE 11-03-2025
- Dividend Yield
- VCYT N/A
- XENE N/A
- EPS Growth
- VCYT N/A
- XENE N/A
- EPS
- VCYT 0.38
- XENE N/A
- Revenue
- VCYT $495,141,000.00
- XENE $7,500,000.00
- Revenue This Year
- VCYT $14.52
- XENE N/A
- Revenue Next Year
- VCYT $9.90
- XENE $207.88
- P/E Ratio
- VCYT $125.41
- XENE N/A
- Revenue Growth
- VCYT 16.41
- XENE N/A
- 52 Week Low
- VCYT $22.61
- XENE $26.74
- 52 Week High
- VCYT $50.71
- XENE $45.01
- Technical
- Relative Strength Index (RSI)
- VCYT 71.15
- XENE 69.92
- Support Level
- VCYT $37.98
- XENE $39.09
- Resistance Level
- VCYT $50.71
- XENE $42.31
- Average True Range (ATR)
- VCYT 2.11
- XENE 1.46
- MACD
- VCYT 0.73
- XENE 0.43
- Stochastic Oscillator
- VCYT 82.09
- XENE 91.45
About VCYT Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.